Emergent BioSolutions (EBS) Interest & Investment Income (2011 - 2018)
Emergent BioSolutions (EBS) recorded Interest & Investment Income of $701,000 in Q3 2018, up 10.0% from $637,000 a year earlier and up 129.1% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Interest & Investment Income (2011 - 2018) Analysis & Trends
On a TTM basis, Emergent BioSolutions' Interest & Investment Income came in at $1.39 million as of Sep 30, 2018, down 26.2% year-over-year; for FY2017, it was $1.75 million, up 66.5% from FY2016.
- Annual Interest & Investment Income has increased for six straight years, with a five-year compound annual growth rate of 67.2% (FY2012 to FY2017).
- Across earlier years, Interest & Investment Income came in at $1.05 million in FY2016 (+84.1%), $572,000 in FY2015 (+78.8%), $320,000 in FY2014 (+130.2%) and $139,000 in FY2013 (+3.7%).
- The Q3 2018 figure is the highest quarterly Interest & Investment Income in data going back to Q2 2011.
- On a year-over-year basis, Interest & Investment Income rose in five of the last eight quarters, with growth averaging 47.2%.
- Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 955.6% in Q4 2014, against a decline of 47.5% in Q2 2018 at the low end.
- Per Business Quant, the preceding three quarters came in at $306,000 (Q2 2018), $222,000 (Q1 2018) and $160,000 (Q4 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | - |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | - |
| 10 | Emergent BioSolutions | 320.11 Mn | -430.79 Mn | 137.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 701,000.00 |
| Jun 30, 2018 | 306,000.00 |
| Mar 31, 2018 | 222,000.00 |
| Dec 31, 2017 | 160,000.00 |
| Sep 30, 2017 | 637,000.00 |
| Jun 30, 2017 | 583,000.00 |
| Mar 31, 2017 | 373,000.00 |
| Dec 31, 2016 | 289,000.00 |
| Sep 30, 2016 | 358,000.00 |
| Jun 30, 2016 | 219,000.00 |
| Mar 31, 2016 | 186,000.00 |
| Dec 31, 2015 | 113,000.00 |
| Sep 30, 2015 | 104,000.00 |
| Jun 30, 2015 | 273,000.00 |
| Mar 31, 2015 | 82,000.00 |
| Dec 31, 2014 | 190,000.00 |
| Sep 30, 2014 | 59,000.00 |
| Jun 30, 2014 | 31,000.00 |
| Mar 31, 2014 | 40,000.00 |
| Dec 31, 2013 | 18,000.00 |
API Access
Emergent BioSolutions Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();